Solifenacin Succinate: Uses, Side Effects & Precautions

Solifenacin succinate (Vesicare) is an antimuscarinic (anticholinergic) medication approved for overactive bladder (OAB) symptoms in adults: urinary urgency, frequency, and urge incontinence.

Mechanism

Competitively blocks M₃ muscarinic receptors on detrusor muscle → inhibits acetylcholine-induced bladder contraction → increases bladder capacity, reduces urgency/frequency.

Dosage

• Standard: 5 mg once daily.
• May increase to 10 mg once daily if tolerated.
• Take with or without food; swallow whole.
• Renal/hepatic impairment: max 5 mg/day.

Common Side Effects (≥2%)

• Dry mouth (most common, ~15–20%)
• Constipation
• Blurred vision
• Urinary retention (monitor in BPH, stricture)
• Nausea, dyspepsia
• Dizziness, fatigue
• Dry eyes

Serious/Notable Risks

• Angioedema (face, lips, throat)—discontinue immediately.
• Central nervous system effects: Confusion, hallucinations, cognitive impairment (higher risk in elderly).
• QT prolongation: Caution with other QT-prolonging drugs, electrolyte abnormalities.
• Heat prostration: Reduced sweating → hyperthermia risk in hot environments.
• Glaucoma exacerbation: Contraindicated in uncontrolled narrow-angle glaucoma.

Contraindications & Cautions

• Urinary retention, gastric retention, uncontrolled narrow-angle glaucoma.
• Severe hepatic impairment (Child-Pugh C).
• Severe renal impairment (CrCl <15 mL/min) or ESRD on dialysis.
• Pregnancy Category C; breastfeeding: use caution.
• Strong CYP3A4 inhibitors (ketoconazole, clarithromycin) → ↑solifenacin levels (max 5 mg).

Monitoring

• Assess OAB symptom improvement at 4–8 weeks.
• Monitor for urinary retention (post-void residual if symptomatic).
• Counsel on hydration, heat avoidance, driving if blurred vision/drowsy.